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Background: Assessment of lymph node status is a critical issue in the surgical management of gallbladder cancer.
The aim of this study was to compare the anatomical location of positive nodes, number of positive nodes, and
lymph node ratio (LNR) as prognostic predictors in gallbladder cancer.
Methods: We conducted a retrospective analysis of 135 patients with gallbladder cancer who underwent a radical
resection with regional lymphadenectomy. A total of 2,245 regional lymph nodes were retrieved (median, 14 per patient).
The location of positive nodes was classified according to the AJCC staging manual (7th edition). ‘Optimal’ cutoff values
were determined for the number of positive nodes and LNR based on maximal χ2 scores calculated with the Cox
proportional hazards regression model.
Results: Lymph node metastasis was found histologically in 59 (44%) patients. The ‘optimal’ cutoff values for the number
of positive nodes and LNR were determined to be three nodes and 10%, respectively. Univariate analysis identified
location of positive nodes (pN0, pN1, pN2; P< 0.001), number of positive nodes (0, 1 to 3, ≥4; P< 0.001), and LNR (0%, 0
to 10%, >10%; P< 0.001) as significant prognostic factors. Multivariate analysis identified number of positive nodes as an
independent prognostic factor (P=0.004); however, location of positive nodes and LNR failed to remain as an
independent variable.
Conclusions: The number of positive lymph nodes better predicts patient outcome after resection than either the
location of positive lymph nodes or LNR in gallbladder cancer. Dividing the number of positive lymph nodes into three
categories (0, 1 to 3, or ≥4) is valid for stratifying patients based on the prognosis after resection.
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Lymph node status (nodal status) is an established prog-
nostic factor in various gastrointestinal malignancies [1-7].
There are three conventional parameters describing nodal
status: the anatomical location of positive lymph nodes
[8,9], the number of positive lymph nodes [4,6,7], and the
lymph node ratio (LNR; the ratio of the number of posi-
tive nodes to the number of nodes evaluated) [1-3].
In the cases of gallbladder cancer, both the American
Joint Committee on Cancer (AJCC; 7th edition) [8] and* Correspondence: shiray@med.niigata-u.ac.jp
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reproduction in any medium, provided the orthe Japanese Society of Biliary Surgery [9] have subdivided
the nodal status into three categories (N0, N1, or N2) and
four categories (N0, N1, N2, or N3), respectively, accord-
ing to the anatomical location of positive lymph nodes. In
2006, Endo et al. [10] first reported that the number of
positive nodes better predicts the prognosis post-resection
than the topographical location of positive nodes in
patients with node-positive gallbladder cancer. In 2010,
we also found that the number of positive nodes better
predicted survival than the location of positive nodes
(as defined by the Japanese Society of Biliary Surgery
[9]) in patients undergoing an R0 resection [11]. However,
in 2011, Negi et al. [12] were the first to report that LNR,
but not the location or number of positive nodes, inde-
pendently predicts survival after resection. Therefore,td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Radical resection procedures for 135 patients
with gallbladder cancer
Procedure Number of patients
Extended cholecystectomy
C + WR + BD + N* 53
C + WR + N 23
C† + N 11
C† + BD + N 6
More extensive resection
C + ERH + BD + N 14
C + Central hepatectomy{ + BD + N 3
C + ELH + BD + N 1
C + Right trisectionectomy + BD + N 1
C + WR + PD + N 15
C + ERH + PD + N 6
C + ERH + PPPD + N 2
*Designated as ‘extended’ radical cholecystectomy at our department since
1982 [11,13,14].
†Cholecystectomy with full-thickness dissection: cholecystectomy combined
with removal of the cystic plate.
{Defined as removal of Couinaud segments IV, V, and VIII.
C, cholecystectomy; WR, wedge resection of the gallbladder fossa; BD,
resection of the extrahepatic bile duct; N, regional lymphadenectomy; ERH,
extended right hepatectomy (right hepatectomy extended to an inferior
portion of Couinaud segment 4); ELH, extended left hepatectomy (left
hepatectomy extended to an inferior portion of right anterior section); PD,
Whipple pancreaticoduodenectomy; PPPD, pylorus-preserving
pancreaticoduodenectomy.
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patients with gallbladder cancer according to prognosis
remains controversial.
The current study compared the prognostic power of
positive node location (as defined by the AJCC; 7th edition
[8]), number of positive nodes, and LNR, by analyzing the
long-term outcomes of 135 patients who underwent a
radical resection for gallbladder cancer. Cutoff points for
both the number of positive nodes and LNR were deter-




From May 1982 to January 2009, 148 consecutive patients
underwent a radical resection for gallbladder cancer in the
study department, defined as a resection of both the pri-
mary tumor and regional lymph nodes. Thirteen patients
with an invasive primary malignant tumor in other organs
were excluded, leaving 135 patients for this retrospective
study. They included 94 women and 41 men with ages
ranging from 37 to 85 (median, 68) years.
Radical resection procedures
A variety of radical resection procedures were performed
in this series, with the choice of procedure based on the
extent of tumor spread in a given patient (Table 1). An
‘extended’ radical cholecystectomy, which was instituted at
our department in 1982, was the most common operation
among our study cohort [11,13,14]; it involved a chole-
cystectomy, wedge resection of the gallbladder fossa with a
rim of non-neoplastic liver tissue (about 2 cm in thickness
or more), resection of a suprapancreatic segment of the
extrahepatic bile duct, and en bloc regional lymph node
dissection. Late-stage diseases often required more exten-
sive resections such as major hepatectomy (defined as
removal of two sections or more extended hepatectomy),
pancreaticoduodenectomy (the Whipple procedure or
pylorus-preserving procedure), or major hepatectomy
combined with pancreaticoduodenectomy (Table 1) [11,14].
In contrast, some patients with early-stage disease, comor-
bid disease(s), or advanced age underwent a less aggressive
resection, omitting the bile duct resection and/or a hepa-
tectomy (Table 1). Although pathological T1 (pT1) tumors
do not warrant radical resection [15], 21 patients with
these tumors also underwent a radical resection because
pT2 or more advanced disease was not ruled out before
resection.
The cohort also included 18 patients who underwent a
combined resection of contiguous tissues comprising the
transverse colon (n = 11), duodenum (n = 4), portal vein
(n = 3), stomach (n = 1), and inferior vena cava (n = 1).
Among the total of 135 patients, 111 underwent an ini-
tial radical resection and 24 underwent a radical secondresection after a prior simple cholecystectomy for pre-
sumed benign disease [16].
Lymph node dissection procedures
The regional lymph nodes of the gallbladder included
the cystic duct, pericholedochal, posterior superior
(posterosuperior) pancreaticoduodenal, retroportal, right
celiac, and hepatic artery node groups [11,14,17]. In most
patients, these node groups were dissected en bloc. In
the patients who underwent a pancreaticoduodenectomy,
the right portion of the superior mesenteric node group
was also dissected together with the above node groups.
In some patients with early-stage disease, advanced
age, or comorbid diseases, a less aggressive regional
lymphadenectomy was performed at the discretion of
the individual surgeons. In this series, 48 patients with
suspected (or confirmed) regional nodal disease also
underwent a dissection of the paraaortic lymph nodes
(cephalad to the origin of the inferior mesenteric artery)
[11,14,17].
Pathological examination
All pathological findings were documented by using the
AJCC cancer staging manual (7th edition) [8]. The primary
tumor was classified as pT1 in 21 patients, pT2 in 59, pT3
in 36, and pT4 in 19. Adenocarcinoma was identified as
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cinoma in 18, squamous cell carcinoma in 2, and un-
differentiated carcinoma in 1. Residual tumor status
was judged as no residual tumor (R0) or microscopic/
macroscopic residual tumor (R1/2).
Immediately after resection, the surgeon(s) retrieved
lymph nodes from the node-bearing adipose tissues of the
fresh surgical specimen, and grouped them according to
location. A total of 2,829 lymph nodes (comprising 2,245
regional and 584 paraaortic nodes) were retrieved from
the 135 patients. A representative section, 3-μm thick, was
cut from each lymph node retrieved, and the nodes exam-
ined for metastases on routine histological examination
using hematoxylin and eosin.
Assessment of the nodal status
The number of positive lymph nodes as well as the total
lymph node count (TLNC) was recorded for each patient.
Paraaortic lymph nodes (if any) were not included in the
TLNC, and any metastases detected in these lymph nodes
were categorized as distant metastases and designated as
pM1 [8]. Thus, in the current study, the number of posi-
tive lymph nodes did not include any positive paraaortic
nodes detected.
Three parameters were used to assess the nodal status
in individual patients: the location of positive lymph
nodes, the number of positive lymph nodes, and LNR.
The location of positive nodes was classified into three
categories: pN0, pN1, pN2, according to the AJCC can-
cer staging manual (7th edition) [8]. LNR was calculated
by dividing the number of positive nodes by the TLNC.
Patient follow-up after resection
Three patients died post-resection during a hospital stay,
giving an in-hospital mortality rate of 2%. Adjuvant treat-
ment after resection was administered at the discretion of
the individual surgeons. Thirty-six patients received oral
administration of 5-fluorouracil or its derivatives. Eight
patients received intravenous administration of 5-fluor-
ouracil alone or in combination with other agents. Six
patients received intravenous administration of gemcita-
bine. No patients received adjuvant radiotherapy.
Patients discharged home were followed regularly in out-
patient clinics every one to six months for at least five
years, with a median follow-up period of 146 (range, 1 to
332) months. At the time of disease status assessment, 53
patients had died of tumor recurrence and 19 patients had
died of other causes with no evidence of tumor recurrence.
One patient was alive with recurrent disease, and the
remaining 62 patients were alive without the disease.
Statistical analysis
Medical records and survival data were obtained for all
patients. The survival time in each patient was definedas the interval between the date of the definitive resection
and the date of the last follow-up or death. Only deaths
from tumor recurrence were treated as failure cases in the
analysis of disease-specific survival (DSS). The Kaplan-
Meier method was used to estimate cumulative DSS rates,
and the log rank test was used to evaluate differences
between groups.
For the number of positive lymph nodes, LNR, and
TLNC, the ‘optimal’ cutoff values were determined
using χ2 scores, which were calculated using the Cox
proportional hazards regression model. Eleven conven-
tional variables (gallstone, type of radical resection, timing
of radical resection, pT classification, pM classification,
histological type, histological grade, lymphatic vessel inva-
sion, venous invasion, perineural invasion, and residual
tumor status) were found to be significant by univariate
analysis (the log rank test; Table 2), and these were
entered as covariates in the model. The maximal χ2 scores
indicate the ‘optimal’ cutoff values [5,18,19].
To determine factors influencing long-term survival
after resection, 15 conventional variables together with
TLNC, the location of positive nodes, the number of posi-
tive nodes, and LNR were tested in the 135 patients
(Table 2). The Cox proportional hazards regression model
using a step-forward fitting procedure was applied to iden-
tify independent factors associated with survival. In this
model, a step-wise selection was used for variable selection
with entry and removal limits of P< 0.05 and P> 0.10,
respectively.
The IBM SPSS Statistics 19 software (IBM Japan,
Tokyo, Japan) was used for all statistical evaluations. All
tests were two-tailed, and P values< 0.05 were taken to
indicate statistical significance.Results
A total of 2,245 regional lymph nodes were retrieved from
the 135 patients, with TLNC per patient ranging from 3 to
55 (median, 14). Of the study patients, 59 (44%) had a
total of 252 positive lymph nodes; the number of positive
nodes ranged from 1 to 26 (median, 2) per patient, and
LNR ranged from 2.6% to 93% (median; 13%).Cutoff values for the number of positive lymph nodes,
lymph node ratio, and total lymph node count
Tables 3 and 4 depict the analysis of number of positive
nodes and LNR by the Cox proportional hazards regres-
sion model. Based on the maximal χ2 score, the ‘optimal’
cutoff value was three nodes for the number of positive
nodes (Table 3) and 10% for LNR (Table 4). Similarly,
the estimated ‘optimal’ cutoff value for TLNC was 16
nodes (data not shown). Based on these results, both the
number of positive nodes and LNR were placed into one
of three categories in subsequent analyses (0, 1 to 3, or ≥4
Table 2 Factors influencing long-term survival after resection in 135 patients with gallbladder cancer
Variable Number of patients Survival rate (%) Univariate analysis Multivariate analysis
5-year 10-year P value Relative risk (95% CI) P value
Age (years) 0.123
≤70 86 66 63
>70 49 52 49
Sex 0.652
Male 41 66 61
Female 94 59 57
Gallstone 0.028 0.003
Absent 73 52 50 2.801 (1.435-5.470)
Present 62 72 68 1.000
Type of radical resection <0.001
Extended cholecystectomy 93 77 76
Major hepatectomy 19 9 9




Timing of radical resection 0.007
Initial radical resection 111 56 52
Radical second resection 24 86 86
Adjuvant chemotherapy 0.093
Absent 85 57 52
Present 50 68 68
Size of the primary tumor (mm) 0.869
≤60 68 61 59
>60 67 61 57
pT classification* <0.001 0.005
pT1 plus pT2 80 87 85 1.000
pT3 plus pT4 55 21 15 3.145 (1.412-6.948)
Total lymph node count (TLNC) 0.102
≤16 76 66 66
>16 59 55 48
Location of positive lymph nodes* <0.001
pN0 76 80 80
pN1 24 57 46
pN2 35 23 20
Number of positive lymph nodes <0.001 0.004
0 76 80 80 1.000
1-3 39 51 41 1.640 (0.784-3.431)
≥4 20 10 10 4.997 (1.905-13.003)
Lymph node ratio (LNR; %) <0.001
0 76 80 80
0-10 22 60 49
>10 37 24 20
pM classification* <0.001 0.014
pM0 109 72 69 1.000
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Table 2 Factors influencing long-term survival after resection in 135 patients with gallbladder cancer (Continued)
pM1 26† 13 7 2.260 (1.178-4.337)
Histological type* <0.001
Adenocarcinoma 114 66 64
Others 21 32 26
Histological grade* 0.001 <0.001
G1 plus G2 96 68 67 1.000
G3 plus G4 39 42 34 3.472 (1.766-6.828)
Lymphatic vessel invasion (L)* <0.001
L0 57 85 83
L1 78 44 41
Venous invasion (V)* <0.001 0.007
V0 74 78 76 1.000
V1 61 41 37 2.445 (1.279-4.673)
Perineural invasion <0.001
Absent 88 77 74
Present 47 29 26
Residual tumor status* <0.001 0.003
R0 121 67 64 1.000
R1 plus R2 14 0 0 3.306 (1.519-7.195)
*According to the AJCC cancer staging manual (7th edition) [8].
†Includes 13 with paraaortic nodal disease.
CI, confidence interval; pT classification, pathological primary tumor classification; pN classification, pathological regional lymph nodes classification; pM
classification, pathological distant metastasis classification; G1, well differentiated; G2, moderately differentiated; G3, poorly differentiated; G4, undifferentiated; L0,
no lymphatic vessel invasion; L1, lymphatic vessel invasion; V0, no venous invasion; V1, microscopic venous invasion; R0, no residual tumor; R1, microscopic
residual tumor; R2, macroscopic residual tumor.
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was divided into two categories (≤16 or> 16).
Factors influencing disease-specific survival after
resection
Univariate analyses identified gallstone, type of radical
resection, timing of radical resection, pT classification,
location of positive lymph nodes (pN0, pN1, pN2),
number of positive lymph nodes (0, 1 to 3, ≥4), LNR (0%, 0
to 10%, >10%), pM classification, histological type, histo-
logical grade, lymphatic vessel invasion, venous invasion,Table 3 Analysis of the number of positive lymph nodes
using the Cox proportional hazards regression model
Cutoff value for positive node number χ2 score P value
0, ≥1 5.217 0.022
0, 1, ≥2 7.832 0.020
0, 1–2, ≥3 7.611 0.022
0, 1–3, ≥4 13.234 0.001
0, 1–4, ≥5 7.213 0.027
0, 1–5, ≥6 5.275 0.072
0, 1–6, ≥7 5.275 0.072
0, 1–7, ≥8 5.233 0.073perineural invasion, and residual tumor status as significant
prognostic factors (Table 2). TLNC failed to significantly
affect DSS.
The univariately significant variables were then entered
into multivariate analyses, with gallstone, pT classification,
number of positive lymph nodes, pM classification, histo-
logical grade, venous invasion, and residual tumor status
remaining as independently significant variables (Table 2).
Neither location of positive lymph nodes nor LNR were
identified as an independent variable by multivariate
analysis.Table 4 Analysis of the lymph node ratio (LNR) calculated
by the Cox proportional hazards regression model
Cutoff value for LNR (%) χ2 score P value
0, 0–5, >5 7.006 0.030
0, 0–10, >10 7.547 0.023
0, 0–15, >15 6.516 0.038
0, 0–20, >20 6.731 0.035
0, 0–25, >25 6.881 0.032
0, 0–30, >30 6.212 0.045
0, 0–35, >35 6.844 0.033
0, 0–40, >40 5.938 0.051
Figure 2 Kaplan-Meier disease-specific survival estimates
according to the location of positive regional lymph nodes. The
median survival time was not reached with a 5-year survival rate of
80% in patients without nodal disease (pN0). The median survival
time was 74 months with a 5-year survival rate of 57% in patients
with pN1 disease. The median survival time was 13 months with a
5-year survival rate of 23% in patients with pN2 disease. The survival
post-resection differed significantly among the groups (P< 0.001).
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survival after resection
DSS after resection did not differ significantly between
the 76 patients with TLNC ≤ 16 (median DSS, not
reached; 5-year DSS, 66%) and the 59 patients with
TLNC> 16 (median DSS, 77 months; 5-year DSS, 55%)
(P= 0.102; Table 2).
We then focused on a subgroup of 76 patients without
nodal disease (pN0) for further survival analysis. Even in
this subgroup of patients, no significant difference in DSS
was noted between 51 with TLNC≤ 16 (median DSS, not
reached; 5-year DSS, 80%) and 25 with TLNC> 16
(median DSS, not reached; 5-year DSS, 82%) (P=0.707).
Impact of nodal status on disease-specific survival after
resection
Nodal disease was significantly associated with lower DSS
in this series (P< 0.001; Figure 1). When the total group
of 135 patients was stratified based on location of positive
lymph nodes, 76 had pN0 disease, 24 had pN1 disease,
and 35 had pN2 disease, revealing that DSS after resection
differed significantly among the groups (Figure 2). When
divided into three groups according to the number of
positive lymph nodes, 76 had 0 positive nodes, 39 had 1 to
3 positive nodes, and 20 had ≥4 positive nodes, revealing
that DSS after resection also differed significantly among
these groups (Figure 3). Finally, groups also differed sig-
nificantly in DSS after resection when divided according
to LNR; 76 had a ratio of 0%, 22 had a ratio of 0 to 10%,
and 37 had a ratio of >10% (Figure 4).
As shown in Table 2, among the three parameters
representing nodal status, only the number of positive
lymph nodes (0, 1 to 3, ≥4) was found to be an inde-
pendent prognostic factor.Figure 1 Kaplan-Meier disease-specific survival estimates
according to the presence or absence of regional nodal
disease. The median survival time was not reached with a 5-year
survival rate of 80% in patients without nodal disease, whereas the
median survival time was 24 months with a 5-year survival rate of
37% in patients with nodal disease (P< 0.001).Discussion
Adequate assessment of the nodal status is a critical
issue in the surgical management of patients with gall-
bladder cancer [10-12,18]. However, among the three
conventional parameters of nodal status, which are loca-
tion of positive lymph nodes, number of positive lymph
nodes, and LNR, what best stratifies the patients withFigure 3 Kaplan-Meier disease-specific survival estimates
according to the number of positive regional lymph nodes. The
median survival time was not reached with a 5-year survival rate of
80% in patients without nodal disease. The median survival time was
63 months with a 5-year survival rate of 51% in patients with 1 to 3
positive nodes. The median survival time was 11 months with a 5-year
survival rate of 10% in patients with ≥4 positive nodes. The survival
post-resection differed significantly among the groups (P< 0.001).
Figure 4 Kaplan-Meier disease-specific survival estimates
according to the lymph node ratio (LNR) of regional lymph
nodes. The median survival time was not reached with a 5-year
survival rate of 80% in patients without nodal disease (LNR of 0%).
The median survival time was 74 months with a 5-year survival rate
of 60% in patients with a LNR of 0 to 10%. The median survival time
was 15 months with a 5-year survival rate of 24% in patients with a
LNR of> 10%. The survival post-resection differed significantly
among the groups (P< 0.001).
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the current study. Here, we demonstrated that only the
number of positive lymph nodes, and not location or
LNR, independently affected outcomes after resection in
our study cohort, suggesting that the number of positive
lymph nodes is a potent parameter in assessing the
nodal status of gallbladder cancer [10,11].
The AJCC cancer staging manual (6th edition) recom-
mended ‘analysis of a minimum of three lymph nodes’ for
accurate staging of gallbladder cancer [20]. However,
recent population-based studies by Coburn et al. [21]
and Mayo et al. [22] disclosed that among patients in
the United States with resectable gallbladder cancer,
only 5.3% to 6.9% had lymphadenectomy of ≥3 lymph
nodes. In 2011, a report from the Memorial Sloan-Kettering
Cancer Center of 122 patients who underwent a portal
lymph node dissection cited a median TLNC of only 3
nodes [18]. The above observations suggest that compliance
with the AJCC recommendation of retrieving a minimum
of three lymph nodes remains poor in the United States. In
general, retrieval of only a few lymph nodes may leave
behind metastatic positive lymph nodes, which could result
in recurrent disease as well as underestimation (that is,,
downstaging) of the nodal status [1-5,12,18].
In contrast, Japanese hepatobiliary surgeons, including
us, maintain an aggressive attitude toward regional
lymphadenectomy for gallbladder cancer [10,11,13,14,23].
As a result of retrieving a large number of lymph nodes,
5-year survival statistics in patients with nodal disease
have improved according to the Japanese literature[10,11,13,14,23]. In the current series, retrieval of a large
number of regional nodes (median of 14 nodes) yielded 19
individuals with nodal disease alive after 5 years (Figure 1).
Coburn et al. [21] and Mayo et al. [22] independently
associated lymphadenectomy accompanied by evaluation
of ≥3 lymph nodes with improved survival among T2 and
T3 patients. Also, Ito et al. [18] and Negi et al. [12] inde-
pendently suggested that retrieval and evaluation of at
least six lymph nodes improves risk-stratification after
resection in node-negative patients. Taken together, the
above observations indicate that retrieval of a larger
number of lymph nodes than previously practiced (for
example, ≥6 nodes [12,18]) is warranted not only for
accurately staging the nodal status, but also for improving
survival due to better clearance of nodal disease. We
believe that adequate lymphadenectomy is indispensable
for improving the prognosis post-resection in patients
with gallbladder cancer [14].
In various gastrointestinal malignancies, evaluating a
limited number of lymph nodes may result in an under-
estimated number of positive nodes, leading to ‘stage mi-
gration’ (that is, downstaging) [1-5,12,18]. To solve this
issue, many investigators have advocated LNR, which is
defined as the number of positive nodes divided by TLNC
[1-3,12]. LNR is of particular value in patients who cannot
adequately be staged because of the limited number of
lymph nodes evaluated [1-3]. Thus, in the case of insuffi-
cient lymph node evaluation, LNR will more accurately re-
flect the nodal status than the number of positive nodes,
as shown for various malignancies [1-3]. Even in gallblad-
der cancer, Negi and colleagues [12] first found that LNR,
and not the number of positive nodes, was an independent
prognostic factor in their study cohort comprising 57
patients with a relatively small TLNC (median of 5 in
node-negative patients; 6 in node-positive patients). Con-
versely, provided that lymph node evaluation is sufficient,
such stage migration will be minimized, and thus the
number of positive nodes will more directly reflect the
nodal status than LNR. This was independently confirmed
by Murakami et al. [4], Lee et al. [7], Sakata et al. [19],
and Sierzega et al. [24] for pancreaticobiliary malignan-
cies. Thus, the sufficient evaluation of regional lymph
nodes in our series (median; 14 nodes per patient) may
partly explain why the number of positive lymph nodes
better stratified the patients than LNR.
Regarding gallbladder cancer, Endo et al. [10] divided
the number of positive lymph nodes into two categories
(1 or ≥2), probably due to no 5-year survivors with mul-
tiple positive nodes in their study cohort. In a previous
study [11], we arbitrarily divided the number of positive
nodes into four categories (0, 1, 2 to 3, or ≥4). In these
two studies, however, cutoff point analysis was not
performed for the number of positive nodes. Although
several statistical methods are used for cutoff point
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calculated by the Cox proportional hazards regression
model (Table 3) and thus determined the cutoff value to
be three positive nodes. We believe that dividing the
number of positive nodes into three categories (0, 1 to
3, or ≥4) is valid for stratifying patients with gallbladder
cancer according to prognosis after resection (Figure 3),
although this observation may be applicable only in
those cases where sufficient lymph node evaluation
(that is, adequate lymphadenectomy) is performed, as in
the current series.
Both the AJCC cancer staging manual (7th edition) [8]
and the Japanese Society of Biliary Surgery [9] categorize
nodal status based on the anatomical location of positive
nodes for gallbladder cancer. In 2006, Endo et al. [10]
suggested that the number of positive nodes is more useful
in assessing nodal status than the location of positive
nodes. In 2010, we additionally showed that the number,
but not location (as defined by the Japanese Society of
Biliary Surgery [9]), of positive nodes independently
determined prognosis after resection. In the current
study, the number of positive nodes better predicted
prognosis post-resection than the location of positive
nodes (as defined by the AJCC cancer staging manual;
7th edition [8]). In addition, the location of lymph nodes
is practically difficult to determine in en bloc resected
specimens. Therefore, the number rather than the location
of positive nodes appears to be a more useful parameter of
nodal status in gallbladder cancer.
The current study has several limitations: the retro-
spective nature of the analysis, the relatively small number
of patients spanning a long period of time, some variability
in the degree of nodal dissection, and the short follow-up
time for some patients. We believe, however, that these
limitations did not greatly affect the results of the study as
the differences between groups were too marked to have
resulted from bias. In addition, the role of the number of
positive nodes in assessing the nodal status for gallbladder
cancer is now more clearly defined than previously based
on the current study. Our results thus provide useful in-
formation for accurately staging nodal disease, predicting
prognosis after resection, and selecting candidates for
adjuvant chemotherapy after resection. The current
study also emphasizes the need to retrieve a larger number
of lymph nodes than ever (for example, ≥6 nodes [12,18])
in resections for gallbladder cancer, not only for accurate
staging but also for clearance of nodal disease.
Conclusions
The number of positive lymph nodes better predicts the
outcome after resection than either location of positive
lymph nodes or LNR in gallbladder cancer, provided that
lymph node evaluation is sufficient. Dividing the number of
positive lymph nodes into three categories (0, 1 to 3, or ≥4)is valid for stratifying patients based on the prognosis after
resection.
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